To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DC33097 | Spongouridine |
Spongouridine is a deamination metabolite of Cytarabine (GLXC-07791).
More description
|
|
| DC33096 | Undecylprodigiosin |
Undecylprodigiosin is a classical cytotoxic immunosuppressant, suppressing immune functions and inhibiting DNA synthesis.
More description
|
|
| DC33095 | CAY 10404 |
CAY10404 is one of the most selective inhibitors of COX-2 over COX-1.
More description
|
|
| DC33093 | ENMD-1068 HBr |
ENMD-1068 HBr is a novel antagonist of Proteinase-Activated Receptor 2 (PAR-2).
More description
|
|
| DC33092 | 1,3-Dicaffeoylquinic acid |
1,3-Dicaffeoylquinic acid is an inhibitor of taste receptors.
More description
|
|
| DC33091 | IWP12 |
IWP-12 is a potent inhibitor of Porcupine (PORCN), a membrane-bound O-acyltransferase (MBOAT).
More description
|
|
| DC33089 | gammaDGG |
gamma-DGG is a broad spectrum glutamate receptor antagonist.
More description
|
|
| DC33088 | Etilevodopa HCl |
Etilevodopa HCl is a prodrug of levodopa with greater gastric solubility and significant brain penetration.
More description
|
|
| DC33087 | MitoB |
MitoB is a novel exomarker of mitochondrial hydrogen peroxide.
More description
|
|
| DC33086 | Spiperone HCl |
Spiperone HCl is a 5-HT2A serotonin and selective D2-like dopamine receptor antagonist.
More description
|
|
| DC33085 | FPL-55712 |
FPL-55712 is a CysLT1 leukotriene receptor antagonist.
More description
|
|
| DC33084 | PPDA |
PPDA is a subtype-selective NMDA receptor antagonist that preferentially binds to NR2C/NR2D-containing receptors.
More description
|
|
| DC33083 | A3 HCl |
A3 HCl is an inhibitor of PKA, PKC, and casein kinase I and II, and MLCK.
More description
|
|
| DC33082 | Amperozide HCl |
Amperozide HCl is a 5-HT2/D2 antagonist, inhibiting nomifensine-induced hyperlocomotion and human FAAH.
More description
|
|
| DC33081 | SC-53116 HCl |
SC-53116 HCl is a psychoactive agent, increasing in production of serotonin in central nervous system tissue.
More description
|
|
| DC33080 | RP106 |
RP-106 is a selective, potent, ATP-competitive inhibitor of CDK1/cyclin B, CDK5/p25, and GSK-3.
More description
|
|
| DC33079 | (-)-MDO-NPA HCl |
(-)-MDO-NPA HCl is an orally effective long-acting agent active at central dopamine receptors, and analogous aporphines.
More description
|
|
| DC33078 | U069593 |
U-69593 is a selective kappa opioid receptor agonist.
More description
|
|
| DC33077 | BCI hydrochloride |
BCI hydrochloride is an allosteric inhibitor of Dusp6, acting within the phosphatase domain to prevent the catalytic stimulation of phosphatase activity induced by ERK2 substrate binding.
More description
|
|
| DC33074 | SB505124 HCl |
SB-505124 HCl is an inhibitor of activin receptor-like kinase (ALK) 5.
More description
|
|
| DC33073 | P18IN 011 |
P18IN011 is a novel p18(INK4C) inhibitor.
More description
|
|
| DC33072 | NMIA |
NMIA, also known as N-Methylisatoic Anhydride, is an RNA SHAPE reagent.
More description
|
|
| DC33070 | Kukoamine B Mesylate |
Kukoamine B Mesylate is potentially for the treatment of sepsis. Kukoamines are a series of bioactive phytochemicals conjugated by a polyamine backbone and phenolic moieties. Treatment with KuB prior to H2O2 exposure effectively increased the cell viability, and restored the mitochondria membrane potential (MMP). Furthermore, KuB enhanced the antioxidant enzyme activities of superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GSH-Px) and decreased the malondialdehyde (MDA) content. Moreover, KuB minimized the ROS formation and inhibited mitochondria-apoptotic pathway, MAPKs (p-p38, p-JNK, p-ERK) pathways, but activated PI3K-AKT pathway.
More description
|
|
| DC33069 | Sinafloxacin Mesylate |
Sinafloxacin Mesylate is a quinolone antibiotic potentially for the treatment of bacterial infections. There is a strong interaction between sinafloxacin and BSA. From thermodynamic coordination it can be judged that the binding force between sinafloxacin and BSA is mainly electro-static force. The effect of sinafloxacin on the conformation of BSA was analyzed by synchronous fluorescence spectrometry and three-dimensional fluorescence spectrometry. The emission maximum of tyrosine residues does not show a significant shift, while the small blue shift of tryptophan residues indicates that the hydrophobicity of microenvironment was increased. In addition, in the plasma, there are some metal ions, which can participate in many important vital actions and affect the reactions of the drugs with the serum albumins.
More description
|
|
| DC33068 | Forodesine |
Forodesine is a transition-state analog inhibitor of purine nucleoside phosphorylase.
More description
|
|
| DC33067 | EMA401 sodium |
Olodanrigan, also known as EMA401, is a novel orally available and highly selective angiotensin II type 2 receptor (AT2R) antagonist.
More description
|
|
| DC33066 | AT2 Agonist C21 |
AT2 Agonist C21 is the first potent and selective agonist of angiotensin AT2 receptors, preventing endothelial inflammation and leukocyte adhesion in vitro and in vivo. AT2 Agonist C21 prevents cognitive decline after permanent stroke in aged animals-A randomized double- blind pre-clinical study. AT2 Agonist C21 attenuates pulmonary inflammation in a model of acute lung injury. AT2 Agonist C21 attenuates the Progression of Lung Fibrosis and Pulmonary Hypertension in an Experimental Model of Bleomycin-Induced Lung Injury.
More description
|
|
| DC33065 | CAY-10471 |
CAY10471, also known as TM30089, is a potent and selective long-lasting antagonist of CRTH2. Cat#527092 is a + rotation. isomer (note sure it is a R-isomer or S-isomer).
More description
|
|
| DC33064 | CGP12177A |
CGP12177A is a partial agonist of ?3-adrenoceptors and antagonist of ?1- and ?2-adrenoceptor.
More description
|
|
| DC33062 | NPPB |
NPPB is a voltage-dependent cystic fibrosis transmembrane conductance regulator (CFTR) channel blocker.
More description
|
|